Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -40.32% is in line with its 5-year average of -38.89%, around the middle of its 5-year range (-65.10%–-27.82%).
As of the fiscal period ended Tuesday, June 30, 2026. 4.10% below its 12-month average of -38.73%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -40.32%.
RETURN ON INVESTED CAPITAL (ROIC)
-40.32%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-38.73%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-41.28%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-38.89%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
-4.10%
CURRENT VS 3Y AVG
+2.34%
CURRENT VS 5Y AVG
-3.68%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-34.44%
median of 684 covered companies
CURRENT VS SECTOR MEDIAN
-17.09%
vs the sector median at left
ORIC Pharmaceuticals, Inc.
Market Cap
$1.24B
Return on Invested Capital (ROIC)
-40.32%
TTM Avg
-38.73%
3Y Avg
-41.28%
5Y Avg
-38.89%
Market Cap
$1.23B
Return on Invested Capital (ROIC)
-0.18%
TTM Avg
-25.12%
3Y Avg
-34.79%
5Y Avg
-34.79%
Market Cap
$1.23B
Return on Invested Capital (ROIC)
1.12%
TTM Avg
-4.20%
3Y Avg
-6.46%
5Y Avg
-10.06%
Market Cap
$1.22B
Return on Invested Capital (ROIC)
9.48%
TTM Avg
1.29%
3Y Avg
-3.62%
5Y Avg
0.10%
Market Cap
$1.22B
Return on Invested Capital (ROIC)
1.32%
TTM Avg
13.41%
3Y Avg
0.51%
5Y Avg
-22.96%
Market Cap
$1.27B
Return on Invested Capital (ROIC)
-57.11%
TTM Avg
-57.11%
3Y Avg
-57.11%
5Y Avg
-57.11%
Market Cap
$1.17B
Return on Invested Capital (ROIC)
-52.44%
TTM Avg
-96.82%
3Y Avg
-100.85%
5Y Avg
-77.97%
Market Cap
$1.32B
Return on Invested Capital (ROIC)
-40.47%
TTM Avg
-45.26%
3Y Avg
-38.46%
5Y Avg
-34.74%
Market Cap
$1.16B
Return on Invested Capital (ROIC)
-12.53%
TTM Avg
-48.13%
3Y Avg
-43.32%
5Y Avg
-40.54%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| ORIC Pharmaceuticals, Inc. (ORIC) | $1.24B | -40.32% | -38.73% | -41.28% | -38.89% |
| Omada Health (OMDA)vs › | $1.23B | -0.18% | -25.12% | -34.79% | -34.79% |
| Cronos Group Inc. (CRON)vs › | $1.23B | 1.12% | -4.20% | -6.46% | -10.06% |
| Innovage Holding Corp. (INNV)vs › | $1.22B | 9.48% | 1.29% | -3.62% | 0.10% |
| MannKind Corporation (MNKD)vs › | $1.22B | 1.32% | 13.41% | 0.51% | -22.96% |
| Kardigan, Inc. (KARD)vs › | $1.27B | -57.11% | -57.11% | -57.11% | -57.11% |
| Damora Therapeutics, Inc. (DMRA)vs › | $1.17B | -52.44% | -96.82% | -100.85% | -77.97% |
| Alpha Tau Medical Ltd (DRTS)vs › | $1.32B | -40.47% | -45.26% | -38.46% | -34.74% |
| Nektar Therapeutics (NKTR)vs › | $1.16B | -12.53% | -48.13% | -43.32% | -40.54% |
| GoodRx Holdings, Inc. (GDRX)vs › | $1.15B | 3.72% | 3.50% | 1.32% | -2.22% |
ROIC
-40.3%
ROE
-36.8%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -40.32% |
| 2026-03-31 | -35.50% |
| 2025-12-31 | -36.30% |
| 2025-09-30 | -36.01% |
| 2025-06-30 | -45.52% |
| 2025-03-31 | -65.10% |
| 2024-12-31 | -57.32% |
| 2024-09-30 | -47.99% |
| 2024-06-30 | -40.44% |
| 2024-03-31 | -34.00% |
| 2023-12-31 | -46.75% |
| 2023-09-30 | -39.73% |
| 2023-06-30 | -35.52% |
| 2023-03-31 | -44.47% |
| 2022-12-31 | -38.62% |
| 2022-09-30 | -41.14% |
| 2022-06-30 | -34.47% |
| 2022-03-31 | -32.51% |
| 2021-12-31 | -27.82% |
| 2021-09-30 | -27.90% |
| 2021-06-30 | -35.42% |
| 2021-03-31 | -29.52% |
| 2020-12-31 | -25.58% |
| 2020-09-30 | -29.60% |
| 2020-06-30 | -18.48% |
| 2020-03-31 | -39.12% |
| 2019-12-31 | -32.19% |
